TherapeuticsMD (TXMD) Current Debt (2011 - 2020)
TherapeuticsMD's Current Debt was -$600,735 in Q2 2013.
Powered by 
Analysis
TherapeuticsMD (TXMD) Current Debt (2011 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.51 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | -5.75 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 208.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 64.00 Mn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 50.00 Mn |
| Jun 30, 2013 | -100,000.00 |
| Mar 31, 2013 | 100,000.00 |
| Sep 30, 2012 | 1.80 Mn |
| Jun 30, 2012 | 4.50 Mn |
| Mar 31, 2012 | 2.40 Mn |
| Dec 31, 2011 | -1.70 Mn |
| Sep 30, 2011 | 1.35 Mn |
| Jun 30, 2011 | 382,905.00 |
| Mar 31, 2011 | 267,244.00 |
API Access
TherapeuticsMD Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-debt&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-debt", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-debt&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();